skip to primary navigationskip to content


last modified Nov 28, 2016 04:07 PM
Stretching Biotech Pharma Entrepreneurship

The annual BioBeat16 event took place on Wednesday 16 November at St Catharine’s College, Cambridge and saw several members of this department being named in the 50 Movers and Shakers in BioBusiness report.

The report nationally recognizes women changing the face and future of healthcare, while inspiring the next generation of Life Science leaders. The report includes women in companies, research, hospitals, finance and advisory roles, 24 of whom are aged under 40.

The three women connected with this department are Theresa Maier, Ipshita Mandal and Sabine Bahn.

Theresa Maier, WD Armstrong Scholar, CEO and Co-founder, JustMilk Limited
Theresa is a PhD student and WD Armstrong Scholar in this department. She has a background in development work and engineering research across four continents. In late 2015, Theresa spun out the for-profit JustMilk Ltd from the JustMilk charity to enable the commercialisation of a novel device for delivering medicines to infants during breastfeeding. It revolutionizes paediatric treatment in low-resource settings by not requiring clean water or medicine refrigeration. In 2016, JustMilk Ltd won both the national McKinsey Venture Academy as well as HRH the Duke of York’s Pitch@Palace 5.0 competition, and was ranked 75 amongst the 100 most disruptive start-ups globally by Tällt Ventures.

Ipshita Mandal, Co-founder and President, Global Biotech Revolution; Chief Business Officer, Bactevo.
Ipshita gained her PhD from this department and this is the second year running that she has been included in the Movers and Shakers list.
Global Biotech Revolution, a student-led think tank, has brought together 275 Leaders of Tomorrow from over 55 countries in Cambridge UK, and in 2017 will convene in Washington DC. The Voices of Tomorrow Global Innovation Completion has developed 40 ideas which have catalysed new ventures such as rare diseases biotech Healx and oncology biotech Oncolinx. Ipshita also leads business operations at Bactevo. Bactevo's access to infinite natural and synthetic chemistry using synthetic biology, microfluidics and AI is being used to discover new antibiotics and drugs against rare diseases.

Sabine Bahn, Professor of Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research, within this department.
As a practising psychiatrist, Sabine's main research interests are to understand the molecular basis of neuropsychiatric disorders, with a focus on schizophrenia and mood disorders. In 2015 she co-founded PsyOmics, together with Dan Cowell. PsyOmics is developing combined digital and blood based biomarker diagnostics to facilitate earlier and improved diagnosis of key mental health disorders. In 2005, Sabine co-founded Psynova Neurotech, which has launched the first blood test aiding the early diagnosis of schizophrenia.
Sabine has published many articles in high impact journals and is a Fellow of the Royal Society of Biology.

BioBeat is a collaborative innovation platform for bioentrepreneurs and leaders. Each autumn, at the BioBeat event, business topics for growing the sector are discussed. On the podium are successful women in the bio sector, and in the audience everyone who wants to build a bio company.

Filed under: ,